LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "bullosa acquisita" as a keyword



Photo from wikipedia

Long-term results of rituximab–intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy

Sign Up to like & get
recommendations! Published in 2017 at "Journal of Dermatological Treatment"

DOI: 10.1080/09546634.2016.1179711

Abstract: Abstract Background: Epidermolysis bullosa acquisita (EBA) is a rare subepidermal bullous disease. Long-term remission in this disease is difficult using current treatments, unlike that in patients with other autoimmune bullous diseases. Objective: We retrospectively evaluated… read more here.

Keywords: combination; bullosa acquisita; treatment; epidermolysis bullosa ... See more keywords
Photo from wikipedia

Reply to "Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease" by Gambichler et al.

Sign Up to like & get
recommendations! Published in 2023 at "Clinical and experimental dermatology"

DOI: 10.1093/ced/llad118

Abstract: Response to “Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease” read more here.

Keywords: bullosa acquisita; acquisita therapy; epidermolysis bullosa; ustekinumab treatment ... See more keywords
Photo by 90angle from unsplash

Epidermolysis bullosa acquisita: a case series of three paediatric patients

Sign Up to like & get
recommendations! Published in 2022 at "Clinical and Experimental Dermatology"

DOI: 10.1111/ced.15112

Abstract: Epidermolysis bullosa acquisita (EBA) is an acquired, subepidermal blistering skin disease characterized by autoantibodies against type VII collagen, which links the epidermis to the dermis at the dermo-epidermal junction. EBA is exceptionally rare in children.… read more here.

Keywords: bullosa acquisita; three paediatric; acquisita case; case series ... See more keywords
Photo by atikahakhtar from unsplash

Efficacy of intravenous immunoglobulins for laryngopharyngeal lesions and upper airway obstruction in epidermolysis bullosa acquisita

Sign Up to like & get
recommendations! Published in 2019 at "Journal of the European Academy of Dermatology and Venereology"

DOI: 10.1111/jdv.16080

Abstract: Epidermolysis bullosa acquisita (EBA) is a rare type of autoimmune blistering disease, which is characterized by autoantibodies against type VII collagen1 . Patients with EBA exhibit blisters or erosions on the skin, especially on the… read more here.

Keywords: intravenous immunoglobulins; epidermolysis bullosa; efficacy intravenous; bullosa acquisita ... See more keywords
Photo by atikahakhtar from unsplash

In utero development of epidermolysis bullosa acquisita

Sign Up to like & get
recommendations! Published in 2019 at "Pediatric Dermatology"

DOI: 10.1111/pde.13704

Abstract: We report the case of an infant born with perioral vesicles that rapidly spread to involve his mouth and the majority of his body. Histopathology, immunofluorescence, and enzyme‐linked immunohistochemistry assays confirmed a diagnosis of epidermolysis… read more here.

Keywords: utero development; epidermolysis bullosa; development epidermolysis; bullosa acquisita ... See more keywords
Photo from wikipedia

Pediatric epidermolysis bullosa acquisita: A review.

Sign Up to like & get
recommendations! Published in 2021 at "Pediatric dermatology"

DOI: 10.1111/pde.14722

Abstract: Epidermolysis bullosa acquisita (EBA) is an acquired autoimmune blistering skin disorder that is rare in adults and even rarer in childhood. This review aims to identify cases of pediatric EBA and report their clinical features… read more here.

Keywords: pediatric epidermolysis; epidermolysis bullosa; review; bullosa acquisita ... See more keywords
Photo by socialcut from unsplash

Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita

Sign Up to like & get
recommendations! Published in 2022 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2022.938306

Abstract: Epidermolysis bullosa acquisita (EBA) is a subepidermal autoimmune bullous disease caused by autoantibodies targeting type VII collagen (COL7). It is characterized by inflammation and subepidermal blistering mainly through immune complex (IC)-mediated activation of neutrophils. In… read more here.

Keywords: bullosa acquisita; riv; neutrophil activation; epidermolysis bullosa ... See more keywords